COMPANY PROFILE // THE 014 REPORT
Tevogen Inc.
TVGN (Nasdaq) · TVGNW (Nasdaq) · Formerly: Tevogen Bio Holdings Inc.; Semper Paratus Acquisition Corp
Assembled from 2 government sources in 2.0 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber5 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-11-04: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-04-22 and 1 more time (last 24 months).
- AmberNT 10-K filed on 2025-04-01: notice that a periodic report would be late.
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Tevogen Inc. is an SEC-registered operating company in biological products, (no diagnostic substances), incorporated in DE, based in Warren, NJ; listed as TVGN (Nasdaq), TVGNW (Nasdaq).[source] It has filed 56 documents with the SEC in the last 12 months; the latest is a S-3, filed 2026-11-17.[source] Its largest institutional holders on 13F filings are VANGUARD CAPITAL MANAGEMENT LLC, AQR CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC (as of 2026-06-30).[source] Seraphix flags 3 items from these records: 8-K Item 3.01 filed; 5 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-11-04; NT 10-K filed on 2025-04-01.[source]
- red0
- amber3
- info0
- VANGUARD CAPITAL MANAGEMENT LLC$136K
- AQR CAPITAL MANAGEMENT LLC$98K
- GOLDMAN SACHS GROUP INC$80K
- JANE STREET GROUP, LLC$63K
- FMR LLC$56K
- Russell Investments Group, Ltd.$37K
- Tower Research Capital LLC (TRC)$8K
- UBS Group AG$6K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Desai Kirti · Chief Financial Officer (Officer) · latest Form 4 2025-12-15 · filing · LinkedIn search
- Flomenberg Neal · See Remarks (Officer) · latest Form 4 2026-03-17 · filing · LinkedIn search
- Khan Sadiq · Chief Commercial Officer (Officer) · latest Form 4 2025-07-01 · filing · LinkedIn search
- Saadi Ryan H. · Chief Executive Officer (Director,Officer,10% owner) · latest Form 4 2025-12-22 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- HOGAN LOVELLS CADWALADER US LLP · Exhibit 5.1 legal opinion, S-3 filed 2026-11-17
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001860871 | source |
| EIN | 98-1597194 | source |
| Business address (SEC) | 15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN, NJ, 07059 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-17 filing S-3 · SEC EDGAR
- 2026-11-16 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-04 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-11-04 officer change 8-K items 5.02 · SEC EDGAR
- 2026-11-03 officer change 8-K items 1.01,2.03,3.02,5.02,9.01 · SEC EDGAR
- 2026-09-30 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-09-16 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-09-16 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-09-16 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-09-10 filing 8-K items 8.01 · SEC EDGAR
- 2026-08-26 officer change 8-K items 5.02,5.03,5.07,9.01 · SEC EDGAR
- 2026-08-24 filing S-8 · SEC EDGAR
- 2026-08-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-03 filing Proxy statement · SEC EDGAR
- 2026-07-30 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-07-30 name change Name changed from Tevogen Bio Holdings Inc. · SEC EDGAR
- 2026-07-23 filing PRE 14A · SEC EDGAR
- 2026-07-14 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-07-10 filing S-8 · SEC EDGAR
- 2026-06-26 filing 424B3 · SEC EDGAR
- 2026-06-25 filing EFFECT · SEC EDGAR
- 2026-06-12 filing S-3 · SEC EDGAR
- 2026-05-15 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-30 filing 10-K/A · SEC EDGAR
- 2026-04-22 filing 8-K items 3.01 · SEC EDGAR
- 2026-03-31 filing Annual report (10-K) · SEC EDGAR
- 2026-03-25 filing 424B3 · SEC EDGAR
- 2026-03-25 filing 8-K items 8.01 · SEC EDGAR
- 2026-03-04 filing 424B3 · SEC EDGAR
- 2026-03-04 filing 8-K items 3.03,5.03,7.01,9.01 · SEC EDGAR
170 earlier entries
- 2026-02-26 filing 424B3
- 2026-02-25 officer change 8-K items 5.02,5.07,9.01
- 2026-02-06 filing 144
- 2026-01-30 filing 8-K items 7.01,9.01
- 2026-01-26 filing Proxy statement
- 2026-01-16 filing PRE 14A
- 2025-12-30 filing 144
- 2025-12-16 filing SCHEDULE 13D/A
- 2025-11-14 filing 424B3
- 2025-11-14 filing Quarterly report (10-Q)
- 2025-09-26 filing 424B3
- 2025-09-26 filing 8-K items 3.01
- 2025-08-14 filing 424B3
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-07-25 filing SCHEDULE 13D/A
- 2025-07-10 filing 424B3
- 2025-07-10 filing 8-K items 8.01
- 2025-07-03 filing 8-K items 1.01,9.01
- 2025-07-03 filing 424B5
- 2025-07-01 insider First Form 3/4/5 on record for Desai Kirti (Chief Financial Officer)
- 2025-07-01 insider First Form 3/4/5 on record for Flomenberg Neal (See Remarks)
- 2025-07-01 insider First Form 3/4/5 on record for Khan Sadiq (Chief Commercial Officer)
- 2025-06-30 filing 8-K items 8.01
- 2025-06-27 filing 424B3
- 2025-06-26 filing EFFECT
- 2025-06-24 filing CORRESP
- 2025-06-24 filing UPLOAD
- 2025-06-23 filing 424B3
- 2025-06-23 filing 8-K items 5.07
- 2025-06-20 filing S-3
- 2025-06-09 filing 144
- 2025-06-09 insider First Form 3/4/5 on record for Saadi Ryan H. (Chief Executive Officer)
- 2025-06-03 filing 424B3
- 2025-06-03 filing 8-K items 1.01,9.01
- 2025-05-14 filing 424B3
- 2025-05-14 filing Quarterly report (10-Q)
- 2025-05-07 filing 424B3
- 2025-05-02 filing EFFECT
- 2025-05-01 filing S-8
- 2025-04-30 filing POS AM
- 2025-04-30 filing DEFA14A
- 2025-04-30 filing Proxy statement
- 2025-04-25 filing DEFA14A
- 2025-04-25 filing 8-K items 5.03,9.01
- 2025-04-17 filing 8-K items 7.01,9.01
- 2025-04-02 filing Annual report (10-K)
- 2025-04-01 filing NT 10-K
- 2025-01-28 filing 424B3
- 2025-01-28 filing 8-K items 7.01,8.01,9.01
- 2024-11-19 filing 424B3
- 2024-11-19 filing Quarterly report (10-Q)
- 2024-11-15 filing NT 10-Q
- 2024-08-26 filing 424B3
- 2024-08-26 filing 8-K/A items 1.01,3.02
- 2024-08-23 filing 424B3
- 2024-08-23 officer change 8-K items 1.01,3.02,5.02,5.03,9.01
- 2024-08-14 filing 424B3
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-08-05 filing 424B3
- 2024-08-02 filing EFFECT
- 2024-08-01 filing CORRESP
- 2024-08-01 filing S-1/A
- 2024-07-31 filing CORRESP
- 2024-07-30 filing UPLOAD
- 2024-07-29 filing CORRESP
- 2024-07-24 filing UPLOAD
- 2024-07-23 filing S-1/A
- 2024-07-23 filing CORRESP
- 2024-07-02 filing UPLOAD
- 2024-06-21 filing Registration (S-1)
- 2024-06-21 filing 8-K items 1.01,1.02,3.01,9.01
- 2024-06-11 filing 8-K items 1.01,2.03,3.02,9.01
- 2024-06-10 filing S-8
- 2024-05-30 filing 8-K/A items 9.01
- 2024-05-28 filing Quarterly report (10-Q)
- 2024-05-16 filing NT 10-Q
- 2024-05-16 filing 8-K items 1.01
- 2024-05-02 filing 8-K items 4.01,9.01
- 2024-04-29 filing 8-K/A items 9.01
- 2024-04-29 filing Annual report (10-K)
- 2024-04-26 filing 8-K items 2.02,9.01
- 2024-04-10 filing 8-K/A items 1.01,3.02,5.03,9.01
- 2024-04-02 filing NT 10-K
- 2024-04-02 filing 8-K items 1.01,5.03,9.01
- 2024-03-21 filing 8-K items 5.03,9.01
- 2024-02-22 filing SC 13D
- 2024-02-22 filing SC 13D
- 2024-02-21 filing 8-K items 5.05,9.01
- 2024-02-20 filing 8-K/A items 1.01,3.02,8.01,9.01
- 2024-02-15 filing CERT
- 2024-02-15 name change Name changed from Semper Paratus Acquisition Corp
- 2024-02-14 filing 8-A12B
- 2024-02-14 officer change 8-K items 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.06,9.01
- 2024-02-14 filing 25-NSE
- 2024-02-01 filing 425
- 2024-02-01 filing 8-K items 5.07,7.01,9.01
- 2024-01-31 filing 425
- 2024-01-24 filing 424B3
- 2024-01-24 filing 425
- 2024-01-24 filing 8-K items 7.01,9.01
- 2024-01-24 filing 424B3
- 2024-01-10 filing 424B3
- 2024-01-05 filing 425
- 2024-01-05 filing 8-K items 7.01,9.01
- 2024-01-04 filing EFFECT
- 2024-01-02 filing CORRESP
- 2023-12-22 filing S-4/A
- 2023-12-22 filing CORRESP
- 2023-12-19 filing 425
- 2023-12-19 filing 8-K/A items 3.03,5.03,5.07,8.01,9.01
- 2023-12-18 filing 425
- 2023-12-18 filing 8-K items 3.03,5.03,5.07,8.01,9.01
- 2023-12-13 filing DEFR14A
- 2023-12-04 filing UPLOAD
- 2023-12-04 filing Proxy statement
- 2023-12-04 filing UPLOAD
- 2023-12-01 filing PRER14A
- 2023-11-27 filing PRER14A
- 2023-11-27 filing CORRESP
- 2023-11-27 filing PRER14A
- 2023-11-22 filing S-4/A
- 2023-11-21 filing CORRESP
- 2023-11-20 filing UPLOAD
- 2023-11-17 filing 425
- 2023-11-17 filing 8-K items 7.01,9.01
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-11-13 filing PRE 14A
- 2023-11-07 filing UPLOAD
- 2023-10-23 filing S-4/A
- 2023-10-23 filing CORRESP
- 2023-10-23 filing 10-Q/A
- 2023-10-11 filing UPLOAD
- 2023-09-29 filing 8-K items 8.01,9.01
- 2023-09-14 filing 425
- 2023-09-14 filing 8-K items 7.01,9.01
- 2023-09-14 filing S-4
- 2023-08-21 filing Quarterly report (10-Q)
- 2023-08-15 filing NT 10-Q
- 2023-07-12 filing 425
- 2023-07-07 filing SC 13D
- 2023-06-29 filing 425
- 2023-06-29 filing 8-K items 1.01,7.01,9.01
- 2023-06-21 filing 3/A
- 2023-06-14 filing 3/A
- 2023-06-08 filing SC 13D/A
- 2023-06-07 officer change 8-K items 1.01,5.02,9.01
- 2023-05-22 filing Quarterly report (10-Q)
- 2023-05-15 filing NT 10-Q
- 2023-05-09 filing 8-K items 1.01,3.01,9.01
- 2023-04-17 filing Annual report (10-K)
- 2023-04-07 filing 8-K items 3.01
- 2023-03-31 filing NT 10-K
- 2023-03-29 filing 8-K items 3.01
- 2023-02-13 filing SC 13D/A
- 2023-02-09 filing 8-K items 5.03,5.07,9.01
- 2023-01-31 filing 8-K items 8.01
- 2023-01-26 filing DEFA14A
- 2023-01-26 filing 8-K items 8.01
- 2023-01-20 filing Proxy statement
- 2023-01-10 filing PRE 14A
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-08-15 filing Quarterly report (10-Q)
- 2022-05-17 filing Quarterly report (10-Q)
- 2022-05-17 filing NT 10-Q
- 2022-04-15 officer change 8-K items 5.02
- 2022-04-01 filing Annual report (10-K)
- 2022-04-01 filing NT 10-K
- 2021-12-30 filing 8-K items 8.01,9.01
- 2021-12-17 filing Quarterly report (10-Q)
- 2021-11-15 filing 8-K items 8.01,9.01
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-17 (within 7 days) S-3 filed
- 2026-11-16 (within 7 days) 10-Q filed
- 2026-11-04 (within 30 days) 8-K filed: Item 5.02 officer or director change
- 2026-11-03 (within 30 days) 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-30 (older) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-09-16 (older) 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-10 (older) 8-K filed: Item 8.01 other event
- 2026-08-26 (older) 8-K filed: Item 5.02 officer or director change; Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:TVGN The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1860871 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | TVGN / Nasdaq, Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 981597194 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001860871 | SEC EDGAR / IRS |
| CUSIP | 88165K200 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001860871 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-12-31) | -$26,275,432 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 10:23 UTC | Report an error |
| Total assets (at 2025-12-31) | $4,382,994 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 10:23 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | -$8,234,726 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 10:23 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $0 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 10:23 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 10:23 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 10:23 UTC | Report an error |
| State of incorporation | DE | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 10:23 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 10:23 UTC | Report an error |
| Business address | 15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN, NJ, 07059 | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 10:23 UTC | Report an error |
| Exchanges | Nasdaq, Nasdaq | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 10:23 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$12,328,577 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 10:23 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $64,439 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 10:23 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,450,490 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 10:23 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001493152-26-052607
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$7,003,801 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052607 | 2026-11-20 10:23 UTC | Report an error |
| Cash and cash equivalents | $144,713 | at 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052607 | 2026-11-20 10:23 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-17 Filing S-3 filed
- 2026-11-16 Filing 10-Q filed
- 2026-11-04 Filing 8-K filed: Item 5.02 officer or director change
- 2026-11-03 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-30 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-09-16 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-10 Filing 8-K filed: Item 8.01 other event
- 2026-08-26 Filing 8-K filed: Item 5.02 officer or director change; Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-08-24 Filing S-8 filed
- 2026-08-14 Filing 10-Q filed
- 2026-08-03 Filing DEF 14A filed
- 2026-07-30 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-07-23 Filing PRE 14A filed
- 2026-07-10 Filing S-8 filed
- 2026-06-26 Filing 424B3 filed
- 2026-06-25 Filing EFFECT filed
- 2026-06-12 Filing S-3 filed
- 2026-05-15 Filing 10-Q filed
- 2026-04-30 Filing 10-K/A filed
- 2026-04-22 Filing 8-K filed: Item 3.01 delisting notice
- 2026-03-31 Filing 10-K filed
- 2026-03-25 Filing 424B3 filed
- 2026-03-25 Filing 8-K filed: Item 8.01 other event
- 2026-03-04 Filing 424B3 filed
- 2026-03-04 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | $135,704 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 2 | AQR CAPITAL MANAGEMENT LLC | $97,561 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 3 | GOLDMAN SACHS GROUP INC | $80,163 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 4 | JANE STREET GROUP, LLC | $63,251 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 5 | FMR LLC | $55,615 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 6 | Russell Investments Group, Ltd. | $36,971 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 7 | Tower Research Capital LLC (TRC) | $8,456 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 8 | UBS Group AG | $6,130 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 9 | VANGUARD FIDUCIARY TRUST CO | $4,743 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
| 10 | GAMMA Investing LLC | $4,313 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:23 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1860871.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001860871. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.